tiprankstipranks
Trending News
More News >
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market
Advertisement

BridgeBio Oncology Therapeutics (BBOT) Income Statement

Compare
14 Followers

BridgeBio Oncology Therapeutics Income Statement

Last quarter (Q3 2025), BridgeBio Oncology Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, BridgeBio Oncology Therapeutics's net income was $-44.76M. See BridgeBio Oncology Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 80.86M$ 64.77M$ 3.52K$ 43.36K$ -90.84K
Depreciation and Amortization
$ 208.00K$ 92.00K$ 0.00$ 0.00$ 206.30K
EBITDA
$ -80.66M$ -64.68M$ -3.52K$ -43.36K$ -90.84K
Operating Income
$ -80.86M$ -64.77M$ 0.00$ -43.36K$ -90.84K
Other Income/Expenses
$ 6.59M$ 72.00K$ 0.00$ 0.00$ 0.00
Pretax Income
$ -74.28M$ -64.70M$ -3.52K$ -43.36K$ -90.84K
Net Income
$ -74.28M$ -64.70M$ -3.52K$ -43.36K$ -90.84K
Per Share Metrics
Basic EPS
$ 0.46$ 0.00$ 0.00$ 0.00$ -0.01
Diluted EPS
$ 0.46$ 0.00$ 0.00$ 0.00$ -0.01
Weighted Average Shares Outstanding
16.64M 20.48M 20.48M 20.48M 14.81M
Weighted Average Shares Outstanding (Diluted)
16.64M 20.48M 20.48M 20.48M 14.81M
Currency in USD

BridgeBio Oncology Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis